MedPath
TGA Approval

DEPO-PROVERA medroxyprogesterone acetate 150 mg/mL aqueous suspension injection vial (12300)

12300

DEPO-PROVERA medroxyprogesterone acetate 150 mg/mL aqueous suspension injection vial

Pfizer Australia Pty Ltd

August 2, 1991

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/3bc149e17f0c1cf00f220ccba84baa03.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/b9b9784e53ac43a4fcb48fb2b1d9cc24.pdf

Active Ingredients

medroxyprogesterone acetate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEPO-PROVERA medroxyprogesterone acetate 150 mg/mL aqueous suspension injection vial (12300) - TGA 批准文号 | MedPath